Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Bristol-Myers Squibb (BMS) and BioMotiv, a drug-development accelerator company that is focused on early-stage drug development, have launched Anteros Pharmaceuticals, a biopharmaceutical company focused on developing drugs for fibrotic and other...

Sandoz, the generics and biosimilars arm of Novartis, has completed its acquisition of the Japanese business of Aspen Global Inc. (AGI), a wholly owned subsidiary of the specialty and branded pharmaceutical company, Aspen Pharmacare, in a deal...

A roundup of developments and latest news from China (WuXi Biologics), India (Biocon), UK (AstraZeneca), US (Krystal Biotech). China WuXi Biologics Provides Update on Activities Relating to Coronavirus in China WuXi Biologics, a contract...

Allergan has opened an EUR 160 million ($176 million) biologics facility at its Westport Campus in County Mayo, Ireland. The new facility will act as a global hub for Allergan’s flagship products, including Botox (onabotulinumtoxinA), one of its...